Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out ...

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.

While doctors haven’t pinpointed exact causes, certain factors significantly increase your chances of developing thyroid cancer. Women face three times higher risk than men, particularly between ...

I wasn’t prepared for what he told me next. “You have textbook thyroid cancer and it is really far spread into your lymph nodes.” I had delayed seeing a doctor because I thought I was ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.

A recent study has revealed an increased risk of thyroid cancer diagnoses within the first year of starting GLP-1RA therapy. Read on!

In some cases, doctors may use the test to diagnose thyroid cancer, or other damage to the thyroid. However, the test is not entirely conclusive. According to the National Health Service (NHS ...

A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer. The study is published in the peer-reviewed ...

“The protective effects of GLP-1s against obesity-associated cancers likely stem from multiple mechanisms,” said ... the risks for medullary thyroid cancer and pancreatic cancer.